Spatio-temporal dependency of radiotherapy induced cardiac toxicity in a novel preclinical model
Lead Research Organisation:
Queen's University Belfast
Department Name: Sch of Medicine, Dentistry & Biomed Sci
Abstract
Radiotherapy is an excellent treatment for many types of cancer and about half of all patients can be cured by its use. Despite its success, radiotherapy can result in harmful side effects which can have severe consequences on the quality of life and survival of patients following treatment. In particular, patients who receive chest radiotherapy for different cancers may develop unwanted side effects in the heart which can be life threatening.
In this project, we will investigate different strategies that may be capable of minimizing the effects of radiotherapy by optimising radiotherapy is delivered. This will focus on avoiding structures in the heart that are very sensitive to radiation and will use a new technique to deliver radiotherapy at very high dose rates called FLASH-RT. We will use this information to design better ways of delivering radiotherapy that will reduce harmful effects in the heart, allowing even higher doses of radiotherapy to delivered which could improve outcomes for patients.
In this project, we will investigate different strategies that may be capable of minimizing the effects of radiotherapy by optimising radiotherapy is delivered. This will focus on avoiding structures in the heart that are very sensitive to radiation and will use a new technique to deliver radiotherapy at very high dose rates called FLASH-RT. We will use this information to design better ways of delivering radiotherapy that will reduce harmful effects in the heart, allowing even higher doses of radiotherapy to delivered which could improve outcomes for patients.
Technical Summary
Radiation induced cardiac toxicity (RICT) is a major cause of morbidity and mortality in patients following radiotherapy for thoracic malignancies. The risk of developing RICT after treatment increases linearly with mean absorbed dose to the heart by >7% per Gy with an apparent low dose threshold. Consequently, no clear dose volume constraints can be defined & current radiotherapy planning recommendations advise dose to the heart be kept as low as possible.
Current clinical heart dose constraints remain poorly defined and are largely predicted on the heart being a uniformly radiosensitive organ. Recent clinical observations have shown a dose sensitive region in the base of the heart that is associated with poor survival outcomes in lung cancer. We have reverse translated these observations in a mouse model showing significant cardiac dysfunction following base irradiation of the heart.
In this project we will use this model to investigate the impact of spatio-temporal radiotherapy delivery parameters on RICT. Our overall aim to optimise treatment planning by integrating regional cardiac dose constraints based on radiosensitive sub-volumes, cardio-pulmonary interplay and effects at ultra-high dose rates (FLASH-RT).
Current clinical heart dose constraints remain poorly defined and are largely predicted on the heart being a uniformly radiosensitive organ. Recent clinical observations have shown a dose sensitive region in the base of the heart that is associated with poor survival outcomes in lung cancer. We have reverse translated these observations in a mouse model showing significant cardiac dysfunction following base irradiation of the heart.
In this project we will use this model to investigate the impact of spatio-temporal radiotherapy delivery parameters on RICT. Our overall aim to optimise treatment planning by integrating regional cardiac dose constraints based on radiosensitive sub-volumes, cardio-pulmonary interplay and effects at ultra-high dose rates (FLASH-RT).
Organisations
Publications
Brown K
(2023)
Development and optimisation of a preclinical cone beam computed tomography-based radiomics workflow for radiation oncology research
in Physics and Imaging in Radiation Oncology
Brown KH
(2022)
A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology.
in Clinical and translational radiation oncology
Brown KH
(2023)
Assessment of Variabilities in Lung-Contouring Methods on CBCT Preclinical Radiomics Outputs.
in Cancers
Friedl AA
(2022)
Radiobiology of the FLASH effect.
in Medical physics
Fukunaga H
(2021)
A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy.
in Clinical oncology (Royal College of Radiologists (Great Britain))
Ghita-Pettigrew M
(2024)
Dose-dependent changes in cardiac function, strain and remodelling in a preclinical model of heart base irradiation.
in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Verhaegen F
(2023)
Roadmap for precision preclinical x-ray radiation studies.
in Physics in medicine and biology
Walls GM
(2023)
Spatial Gene Expression Changes in the Mouse Heart After Base-Targeted Irradiation.
in International journal of radiation oncology, biology, physics
Walls GM
(2022)
Murine models of radiation cardiotoxicity: A systematic review and recommendations for future studies.
in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Description | Atrial Natriuretic Peptide as a Biomarker and Therapeutic Target in Radiation Cardiotoxicity |
Amount | £33,481 (GBP) |
Funding ID | RCCPOB-Nov22/100010 |
Organisation | Cancer Research UK |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 02/2023 |
End | 02/2024 |
Description | Establishing a UK National Preclinical Photon-FLASH Radiotherapy Facility (FLASH-SARRP) |
Amount | £798,610 (GBP) |
Funding ID | MC_PC_MR/X012433/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2022 |
End | 03/2023 |
Title | In vivo model of cardiac toxicity following base irradiation |
Description | We have developed an In vivo model of cardiac toxicity following targetted irradiation of the heart base and application of spatial transcriptomic to assess gene expression changes. |
Type Of Material | Database/Collection of data |
Year Produced | 2023 |
Provided To Others? | Yes |
Impact | In vivo model of cardiac toxicity following targetted irradiation of the heart base and application of spatial transcriptomic to assess gene expression changes |
URL | https://doi.org/10.1016/j.ijrobp.2022.08.031 |
Description | CRUK RADNET RADIOTHERAPY-DRUG COMBINATIONS TRAINING WORKSHOP |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | CRUK RadNet Radiotherapy-Drug Combinations Training Workshop attended by Post Doctoral Researchers and Clinical Oncologists |
Year(s) Of Engagement Activity | 2023 |
Description | Invited speaker at online panel event - Xstrahl Life Sciences |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Industry/Business |
Results and Impact | Invited speaker at online panel event - Xstrahl Life Sciences |
Year(s) Of Engagement Activity | 2021 |
Description | Particpation in Conference Talk - iNanoTheRad, Univserity of Paris Sud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | Talk at online conference (iNanoTherAD) |
Year(s) Of Engagement Activity | 2021 |
Description | Patrick G Johnston Cancer Centre Open Day |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Cancer Centre Open Day that was attended by around 200 members of the public, patients, and caregivers. |
Year(s) Of Engagement Activity | 2023 |